Omeros (OMER) Operating Expenses (2010 - 2026)
Omeros' (OMER) quarterly Operating Expenses came in at $27.3 million in Q1 2026, down 21.89% year-on-year from $35.0 million in Q1 2025, and down 6.08% quarter-over-quarter from $29.1 million in Q4 2025.
Omeros (OMER) Operating Expenses (2010 - 2026) Analysis & Trends
Omeros has disclosed Operating Expenses across 17 years of filings, most recently posting $27.3 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $27.3 million, down 21.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $115.1 million (down 29.31% YoY), and the FY2025 annual result was $122.8 million, down 26.45% from the prior year.
- Operating Expenses came in at $27.3 million for Q1 2026 at Omeros, down from $29.1 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $59.2 million in Q2 2024 to a low of $26.4 million in Q3 2025.
- The 5-year median for Operating Expenses is $35.7 million (2023), against an average of $37.9 million.
- Across the five-year window, Operating Expenses surged 44.64% in 2024 and sank 45.31% in 2025, its largest moves.
- Omeros' Operating Expenses stood at $40.1 million in 2022, then slipped by 0.93% to $39.8 million in 2023, then declined by 16.12% to $33.4 million in 2024, then declined by 12.81% to $29.1 million in 2025, then fell by 6.08% to $27.3 million in 2026.
- The last three Operating Expenses figures came in at $27.3 million (Q1 2026), $29.1 million (Q4 2025), and $26.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 27.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.31 Mn |
| Dec 31, 2025 | 29.08 Mn |
| Sep 30, 2025 | 26.39 Mn |
| Jun 30, 2025 | 32.35 Mn |
| Mar 31, 2025 | 34.97 Mn |
| Dec 31, 2024 | 33.36 Mn |
| Sep 30, 2024 | 35.41 Mn |
| Jun 30, 2024 | 59.16 Mn |
| Mar 31, 2024 | 39.03 Mn |
| Dec 31, 2023 | 39.77 Mn |
| Sep 30, 2023 | 48.15 Mn |
| Jun 30, 2023 | 40.90 Mn |
| Mar 31, 2023 | 35.71 Mn |
| Dec 31, 2022 | 40.14 Mn |
| Sep 30, 2022 | 50.77 Mn |
| Jun 30, 2022 | 37.44 Mn |
| Mar 31, 2022 | 35.05 Mn |
| Dec 31, 2021 | 42.89 Mn |
| Sep 30, 2021 | 39.83 Mn |
| Jun 30, 2021 | 45.61 Mn |